bioRxiv/medRxiv TRiP Review Activity

428 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 13: Articles 121-130  | Next

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1
Rincon-Torroella, J., Dal Molin, M., Mog, B., Han, G., Watson, E., Wyhs, N., Ishiyama, S., Ahmedna, T., Minn, I., Azad, N. S., Bettegowda, C., Papadopoulos, N., Kinzler, K. W., Zhou, S., Vogelstein, B., Gabrielson, K. L., Sur, S.
10.1101/2023.07.23.550207 — Posted: 2023-07-25 — Discussion: 2024-09-24  eLife
Super-Enhancer Driven ZFP36L1 Promotes PD-L1 Expression in Infiltrative Gastric Cancer
Wei, X., Liu, J., Zhuo, H., Cheng, J., Cai, W., Xie, W., Wang, K., Lin, L., Hou, J., Cai, J.
10.1101/2024.05.22.595316 — Posted: 2024-05-23 — Discussion: 2024-09-20  eLife
Regulation of lung cancer initiation and progression by the stem cell determinant Musashi
Barber, A. G., Quintero, C. M., Hamilton, M., Rajbhandari, N., Sasik, R., Zhang, Y., Kim, C., Husain, H., Sun, X., Reya, T.
10.1101/2024.04.11.589053 — Posted: 2024-04-15 — Discussion: 2024-09-12  eLife
Proteomic analysis reveals microvesicles containing NAMPT as mediators of radiation resistance in glioma
Panizza, E., Regalado, B. D., Wang, F., Nakano, I., Vacanti, N. M., Cerione, R. A., Antonyak, M. A.
10.1101/2022.03.23.485479 — Posted: 2022-03-23 — Discussion: 2024-09-11  EMBO Press
The T Cell Receptor beta Chain Repertoire of Tumor Infiltrating Lymphocytes Improves Neoantigen Prediction and Prioritization
Pham, T. M. Q., Nguyen, T. N., Nguyen, B. Q. T., Nguyen, H. T. P., Tran, T. P. D., Pham, N. M. D., Ho, T. K. C., Nguyen, D. V. L., Nguyen, H. T., Tran, D. H., Tran, T. S., Pham, T.-V. N., Le, M.-T., Nguyen, T. T. V., Phan, M.-D., Giang, H., Nguyen, H.-N., Tran, L. S.
10.1101/2023.11.16.567478 — Posted: 2023-11-17 — Discussion: 2024-09-10  eLife
TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis
Ju, Q., Sheng, W., Zhang, M., Chen, J., Wu, L., Liu, X., Fang, W., Shi, H., Sun, C.
10.1101/2024.03.22.586256 — Posted: 2024-03-27 — Discussion: 2024-09-09  eLife
Generating specific homologous neutralizing-antibodies: a novel therapeutic strategy in cancer treatment
Liu, Z.
10.1101/2023.07.26.550693 — Posted: 2023-07-29 — Discussion: 2024-08-30  eLife
Engineering PEG10 assembled endogenous virus-like particles with genetically encoded neoantigen peptides for cancer vaccination
Tang, R., Guo, L., Wei, T., Chen, T., Yang, H., Ye, H., Lin, F., Zeng, Y., Yu, H., Cai, Z., Liu, X.
10.1101/2024.04.25.591213 — Posted: 2024-04-27 — Discussion: 2024-08-29  eLife
Inhibition of O-GlcNAc transferase activates type I interferon-dependent antitumor immunity by bridging cGAS-STING pathway
Chen, J., Zhao, B., Li, T., Dong, H., Cheng, X., Gong, W., Wang, J., Zhang, J., Xin, G., Yu, Y., Lei, Y., Black, J., Li, Z., Wen, H.
10.1101/2023.12.14.571787 — Posted: 2023-12-15 — Discussion: 2024-08-29  eLife
Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomas
Fajac, A., Simeonova, I., Leemput, J., Gabriel, M., Morin, A., Lejour, V., Hamon, A., Vaysse-Zinkhofer, W., Eldawra, E., Rakotopare, J., Pinskaya, M., Morillon, A., Bourdon, J.-C., Bardot, B., Toledo, F.
10.1101/2023.10.13.562180 — Posted: 2023-10-18 — Discussion: 2024-08-22  eLife

Evaluation Sources